TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP. Stock

Certificat

DE000SB07408

Real-time Boerse Frankfurt Warrants 10:13:47 2024-05-13 am EDT
11.46 EUR -3.21% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP.
Current month-5.73%
1 month-12.62%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-13 11.46 -3.21% 0
24-05-10 11.84 0.00% 0
24-05-09 11.84 +1.89% 0
24-05-08 11.62 -1.86% 0
24-05-07 11.84 +4.59% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 10:13 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SB0740
ISINDE000SB07408
Date issued 2020-06-09
Strike 204.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.62
Lowest since issue 1.17
Spread 0.04
Spread %0.35%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW